Search research articles
Contact Us
Filters
Showing results (291-300 of 753) with videos related to
Page
of 76
Sort By:
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]
|
July 29, 2015
Best management of locally advanced inoperable breast cancer
Giuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy
R A Joss, R L Galeazzi, A Bischoff, et al.
Expert Opinion on Investigational Drugs
|
January 11, 2012
Targeting the subtypes of breast cancer: rethinking investigational drugs
Giuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Onkologie
|
December 1, 1985
[Total abdominal irradiation following combination chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancer]
R Greiner, A Goldhirsch, E Dreher, et al.
Journal of the National Cancer Institute
|
August 7, 1996
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
R D Gelber, A Goldhirsch, B F Cole, et al.
Anticancer Research
|
June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence
Carmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2006
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
G Sanna, K Lorizzo, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2008
Anthracyclines for gestational breast cancer: course and outcome of pregnancy
H A Azim, F A Peccatori, G Scarfone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2006
First--select the target: better choice of adjuvant treatments for breast cancer patients
A Goldhirsch, A S Coates, R D Gelber, et al.
The Annals of Pharmacotherapy
|
October 26, 2006
Erlotinib-induced breast cancer regression
Chiara Catania, Tommaso Martino De Pas, Giuseppe Pelosi, et al.
Page
of 76
Search research articles
Search
Showing results (291-300 of 753) with videos related to
Sort By:
Page
of 76
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]
|
July 29, 2015
Best management of locally advanced inoperable breast cancer
Giuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy
R A Joss, R L Galeazzi, A Bischoff, et al.
Expert Opinion on Investigational Drugs
|
January 11, 2012
Targeting the subtypes of breast cancer: rethinking investigational drugs
Giuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Onkologie
|
December 1, 1985
[Total abdominal irradiation following combination chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancer]
R Greiner, A Goldhirsch, E Dreher, et al.
Journal of the National Cancer Institute
|
August 7, 1996
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
R D Gelber, A Goldhirsch, B F Cole, et al.
Anticancer Research
|
June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence
Carmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2006
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
G Sanna, K Lorizzo, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2008
Anthracyclines for gestational breast cancer: course and outcome of pregnancy
H A Azim, F A Peccatori, G Scarfone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 31, 2006
First--select the target: better choice of adjuvant treatments for breast cancer patients
A Goldhirsch, A S Coates, R D Gelber, et al.
The Annals of Pharmacotherapy
|
October 26, 2006
Erlotinib-induced breast cancer regression
Chiara Catania, Tommaso Martino De Pas, Giuseppe Pelosi, et al.
Page
of 76